*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>This compound is a specialized <strong>pharmaceutical intermediate</strong> featuring a chiral 1,3-dioxane scaffold linked to a fluorinated quinoline moiety. Synthesized via asymmetric catalysis and Wittig olefination, it serves as a critical building block for antiviral agents. <strong>Molecular Formula</strong>: C26H24FNO3; <strong>CAS No.</strong>: 1009578-58-6.</p>
<h3>Application</h3>
<ul>
<li><strong>Antiviral Drug Manufacturing</strong>: Precursor for HCV protease inhibitors targeting NS3/4A.</li>
<li><strong>Medicinal Chemistry</strong>: Used in lead optimization for nucleoside analog therapies.</li>
<li><strong>Research & Development</strong>: Standard reference material for stereochemical studies.</li>
</ul>
<h3>Precautions</h3>
<p>Store under inert atmosphere at -20°C to prevent hydrolysis. Handle with PPE due to potential irritancy. Not approved for direct clinical use; strictly for industrial synthesis only.</p>